Difference between revisions of "Esophageal adenocarcinoma"

Jump to navigation Jump to search
no edit summary
(usu CK20 -ve)
 
Line 96: Line 96:


==IHC==
==IHC==
*CK7 +ve.
Features:<ref name=pmid14631371>{{cite journal |authors=Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, Penninckx F, Geboes K, Ectors N |title=Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications |journal=Mod Pathol |volume=17 |issue=1 |pages=49–55 |date=January 2004 |pmid=14631371 |doi=10.1038/modpathol.3800011 |url=}}</ref>
*CK20 -ve.<ref name=pmid14631371>{{cite journal |authors=Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, Penninckx F, Geboes K, Ectors N |title=Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications |journal=Mod Pathol |volume=17 |issue=1 |pages=49–55 |date=January 2004 |pmid=14631371 |doi=10.1038/modpathol.3800011 |url=}}</ref>
*CK7 +ve (54 of 66 cases).
*CK20 -ve (14 of 66 cases).
 
Note:
*CK7 +ve and CK20 -ve is seen in ~67% cases (44/66).<ref name=pmid14631371/>


To rule-out SCC:
To rule-out SCC:
48,466

edits

Navigation menu